Chewable Tablet Or Wafer Patents (Class 424/441)
-
Patent number: 8628794Abstract: The present invention is directed to palatable ductile chewable veterinary composition for oral administration. The composition is capable of killing endo-parasites and ecto-parasites and/or can be used for treating prophylactic or curative animal diseases, and it is useful for the treatment of any warm-blooded non-human animal, including herd animals, like horses, cattle, sheep or poultry and preferably pets like dogs and cats. It consists basically of (A) an effective amount of one or more ingredients that are active against animal pests, pathogens or animal diseases; (B) meat flavoring; (C) partially gelatinized starch; (D) a softener; and (E) up to 9% water.Type: GrantFiled: July 29, 2004Date of Patent: January 14, 2014Assignee: Novartis AGInventor: Ute Isele
-
Patent number: 8623401Abstract: An orally administrable wafer is provided comprising at least one physiologically acceptable film forming agent. The wafer is formed by mixing the film-forming agent with an aqueous solution to form a gel and exposing the gel to a plurality of heating and cooling cycles. The wafer is rapidly dissolving and suitable for administration of pharmaceutical agents.Type: GrantFiled: March 27, 2008Date of Patent: January 7, 2014Assignee: Fenwafe Inc.Inventor: Pankaj Modi
-
Publication number: 20130309292Abstract: The invention relates to a tobacco alkaloid releasing chewing gum comprising tobacco alkaloid, gum base, and chewing gum ingredients, said gum base comprising elastomer and resin-compounds constituting an amount in the range of about 2 to 20% by weight of said chewing gum.Type: ApplicationFiled: July 23, 2013Publication date: November 21, 2013Inventor: Carsten Andersen
-
Patent number: 8568767Abstract: The present invention provides a chewable composition containing granules of water-soluble dietary fiber. The chewable composition has highly agreeable organolpetic properties and is consumable without the need of an ingestion aid.Type: GrantFiled: January 9, 2013Date of Patent: October 29, 2013Assignee: Novartis AGInventors: Nils William Ahlgren, Ronald Lee Dahl, Monte Lee Friesen, Alexander Mark Schobel
-
Patent number: 8545881Abstract: A tablet that rapidly disintegrates in the oral cavity comprising a compressed blend of rapidly dispersing microgranules prepared by granulating a sugar alcohol or a saccharide or a mixture thereof having an average particle size less than about 30 microns and a disintegrant, and a taste-masked microcapsule containing at least one drug, the microcapsule being prepared by granulating a pharmaceutically acceptable formulation comprising at least one drug in a therapeutically effective amount and at least one polymeric binder that improves resilience of the microgranules, wet milling the granulated mass, and microencapsulating the milled granules to provide microcapsules.Type: GrantFiled: April 19, 2004Date of Patent: October 1, 2013Assignee: Eurand Pharmaceuticals, Ltd.Inventors: Gopi M. Venkatesh, Ken Kangyi Qian, Shyam Vangala, James M. Clevenger, Donald Guenther
-
Patent number: 8541019Abstract: The present invention is directed to palatable ductile chewable veterinary composition for oral administration. The composition is capable of killing endo-parasites and ecto-parasites and/or can be used for treating prophylactic or curative animal diseases, and it is useful for the treatment of any warm-blooded non-human animal, including herd animals, like horses, cattle, sheep or poultry and preferably pets like dogs and cats. It consists basically of (A) an effective amount of one or more ingredients that are active against animal pests, pathogens or animal diseases; (B) meat flavoring; (C) partially gelatinized starch; (D) a softener; and (E) up to 9% water.Type: GrantFiled: October 31, 2011Date of Patent: September 24, 2013Assignee: Novartis AGInventor: Ute Isele
-
Patent number: 8535660Abstract: The present invention relates to different nutritional supplements to be administered to, or taken by, pregnant women during the first, second and third trimesters of pregnancy.Type: GrantFiled: November 7, 2011Date of Patent: September 17, 2013Assignee: Argent Development Group, LLCInventors: John C. Morrison, Kenneth R. Greathouse
-
Patent number: 8535659Abstract: The present invention relates to different nutritional supplements to be administered to, or taken by, pregnant women during the first, second and third trimesters of pregnancy.Type: GrantFiled: May 21, 2009Date of Patent: September 17, 2013Assignee: Argent Development Group, LLCInventors: John C. Morrison, Kenneth R. Greathouse
-
Patent number: 8506989Abstract: The invention relates to a preparation comprising a creatine component, which has excellent bio-availability and leads to improved creatine retention in the human and animal body. The present invention further relates to a method for the production of said preparation, and to the use thereof as a nutritional supplement, functional food, animal feed additive, pharmaceutical, and as an additive for cosmetic and dermatologic formulations.Type: GrantFiled: December 18, 2008Date of Patent: August 13, 2013Assignee: AlzChem Trostberg GmbHInventors: Thomas Gastner, Frauke Warrikoff, Barbara Nieβ, Josef Fuest
-
Patent number: 8506990Abstract: Provided are methods of treating pain, including neuropathic pain, in human and veterinary individuals. These methods employ locally administrable pharmaceutical gallium compositions, including pharmaceutical gallium compositions suitable for administration to the skin and mucous membranes. The compositions comprise pharmaceutically acceptable gallium compounds, such as gallium maltolate or gallium nitrate, together with pharmaceutically acceptable carriers suitable for local administration, including those suitable for topical administration. The administration of such compositions provides relief from pain, itching, allodynia, hyperalgesia, and related symptoms.Type: GrantFiled: October 10, 2012Date of Patent: August 13, 2013Inventor: Lawrence Richard Bernstein
-
Patent number: 8507462Abstract: Methods of controlling serum glucose levels in an individual are described, the methods including the step of administering to said individual a therapeutic food composition comprising a waxy and/or hydrothermally treated starch. The method may be used to treat or prevent hypoglycaemia in patients susceptible to hypoglycaemic episodes, for example patients with glycogen storage disease, diabetes or liver disease. The method may also be used in sports nutrition. Also described are compositions for use in the methods.Type: GrantFiled: November 8, 2004Date of Patent: August 13, 2013Assignee: Glycologic LimitedInventors: Xin Qi, Richard Tester
-
Patent number: 8496969Abstract: The invention relates to an immediate release tablet capable of being chewed or disintegrated in the oral cavity, which comprises a pharmaceutically active ingredient having an optional tastemasking coating, and a matrix comprising hydroxyalkylcellulose having a weight average molecular weight of from about 60,000 to about 5,000,000. The tablet possesses exceptionally good mouthfeel and stability.Type: GrantFiled: December 15, 2009Date of Patent: July 30, 2013Assignee: McNeil-PPC, Inc.Inventors: David Wynn, Nick Parikh
-
Patent number: 8454989Abstract: A method of manufacturing a bioactive fluid dose on an ingestible sheet, comprising the steps of advancing the ingestible sheet to a dispense position, and activating a fluid ejector to dispense essentially a drop of a bioactive fluid onto the ingestible sheet.Type: GrantFiled: April 20, 2005Date of Patent: June 4, 2013Assignee: Hewlett-Packard Development Company, L.P.Inventors: Brian Craig Lee, Steven W. Steinfield, Winthrop D. Childers, Mark A. Van Veen, Mohammad M. Samii
-
Patent number: 8454951Abstract: The present invention relates to nutritional supplements to be administered to, or to be taken by, women desiring to become pregnant, and pregnant and nursing women. The nutritional supplements of this invention have a unique blend of vitamins, minerals, lycopene, co-enzyme Q10, DHA, docusate (such as docusate sodium), folic acid, and a nutritionally acceptable carrier therefor. The invention includes specific nutritional supplements for the uses set forth above.Type: GrantFiled: April 28, 2011Date of Patent: June 4, 2013Assignee: Argent Development Group, LLCInventors: John C. Morrison, Kenneth R. Greathouse
-
Publication number: 20130115266Abstract: A food product for carrying and delivery nutraceutical or pharmaceutical or both is provided. The food product may be an edible wafer-based outer layer and an inner layer of an edible filling comprising the nutraceutical or pharmaceutical or both.Type: ApplicationFiled: November 1, 2012Publication date: May 9, 2013Applicant: BestSweet, Inc.Inventor: BestSweet, Inc.
-
Patent number: 8414916Abstract: A matrix formulation for a soft chewable capsule is provided which includes a gel-forming composition, a plasticizer, a polymer modifier, and water. The polymer modifier may be a carboxylic acid or other organic compound that alters the physical and/or chemical properties of the capsule formulation. A chewable soft capsule is also provided, having enhanced organo-leptic and processing properties. An active material may be delivered to a user using this dosage form. A method of forming the chewable soft capsule is also provided.Type: GrantFiled: June 8, 2012Date of Patent: April 9, 2013Assignee: Banner Pharma Caps, Inc.Inventors: EmadEldin M. Hassan, Warren W. Kindt, Roger E. Gordon
-
Patent number: 8394401Abstract: In this application, an antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine component(s) that is characterized in that said food, feeding stuff or supplement contains lysine component(s) at such rate that 40 to 160 mg in terms of free-form lysine should be taken in per kg of body weight per day, under diet conditions under which the daily protein energy composition is 20% or less, and an antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine component(s) that is characterized by containing said lysine component(s) in an amount of 0.8 to 3.0 wt % in terms of free-form lysine on the basis of the dry matter and having a protein energy composition of 20% or less are disclosed.Type: GrantFiled: April 27, 2005Date of Patent: March 12, 2013Assignee: Ajinomoto Co., Inc.Inventors: Yuri Hirabayashi, Hitoshi Murakami, Hisamine Kobayashi, Takeo Ueda
-
Patent number: 8383146Abstract: A process for the preparation of a composition intended for the oral administration of active principles with unacceptable taste, which comprises from about 15% to about 30% of organoleptically unpleasant active ingredient (principle) that is mixed with from about 60% to about 80% of an ester of glycerol or of a fatty acid, to which a wax is optionally added and to which a surfactant is added, and in that it is prepared by a spray-cooling process which can produce a particle size of less than 350 ?m.Type: GrantFiled: January 27, 2012Date of Patent: February 26, 2013Assignee: SanofiInventors: Isabelle Chacornac, Patricia Probeck
-
Patent number: 8372428Abstract: A soft capsule in which a shell is filled with fill material, and the fill material is in a solid or semi-solid form at room temperature. The soft capsule may be a chewable capsule, and the fill material may comprise a low melting point additive. The content of the low melting point additive may be 10% or more with respect to the total weight of the fill material, and may have a melting point of about 20 to 50° C. The low melting point additive may be selected from the group consisting of chocolate base, lard, coconut oil and macrogol (polyethylene glycol) as well as a combination thereof.Type: GrantFiled: June 11, 2010Date of Patent: February 12, 2013Assignee: Shionogi & Co., Ltd.Inventors: Hidekazu Shodai, Noboru Nagafuji, Toshitada Toyoda, Yuka Okada
-
Patent number: 8361519Abstract: An herbal composition for providing a beneficial effect to the respiratory tract. The composition includes Thyme Leaf, Wild Cherry Bark, Cocoa Extract, Mullein Leaf Extract, and Boswellia Serrata. In particular, the composition may prevent or treat cough, specifically caused by exposure to smoke. Also described are methods of using the herbal composition.Type: GrantFiled: November 16, 2011Date of Patent: January 29, 2013Assignee: Aadvantics Pharmaceuticals, Inc.Inventors: Brian M. Levine, William E. Berger
-
Patent number: 8329190Abstract: The invention relates to a composition for modulating the immune responses induced by Gram negative bacteria, potential pathogenic Gram positive bacteria and/or their derivatives, comprising lipoteichoic acid from lactic acid bacteria as an active ingredient. It also relates to the use of a lipoteichoic acid from lactic acid bacteria as an active ingredient and/or lactic acid bacteria producing it and/or its supernatant of culture, in the manufacture of a medicament, an oral or topical product for cosmetic, dermatological or ophtalmological applications, a food or petfood composition for modulating bacterial colonization, immune responses and decreasing the inflammatory processes associated with bacterially-mediated disease and infection in the gastrointestinal tract, bone, skin, eye, ear, lung and oral cavity. The invention also relates to lipoteichoic acid selected thereof.Type: GrantFiled: October 7, 2008Date of Patent: December 11, 2012Assignees: Societe des Produits Nestle S.A., Nestec S.A.Inventors: Karine Vidal, Anne Donnet-Hughes, Dominique-Anne Granato, Irene Corthesy-Theulaz
-
Patent number: 8309118Abstract: Water soluble, gelatin-free dip coatings for substrates comprising a hydrocolloid, such as carrageenan, and sucralose.Type: GrantFiled: June 21, 2002Date of Patent: November 13, 2012Assignee: McNeil-PPC, Inc.Inventor: Christopher E. Szymczak
-
Patent number: 8293268Abstract: Provided are methods of treating pain, including neuropathic pain, in human and veterinary individuals. These methods employ locally administrable pharmaceutical gallium compositions, including pharmaceutical gallium compositions suitable for administration to the skin and mucous membranes. The compositions comprise pharmaceutically acceptable gallium compounds, such as gallium maltolate or gallium nitrate, together with pharmaceutically acceptable carriers suitable for local administration, including those suitable for topical administration. The administration of such compositions provides relief from pain, itching, allodynia, hyperalgesia, and related symptoms.Type: GrantFiled: March 14, 2012Date of Patent: October 23, 2012Inventor: Lawrence Richard Bernstein
-
Patent number: 8252312Abstract: The present invention provides an oral solid composition comprising a lipase inhibitor, an acid soluble polymer and an excipient. The composition may further comprise a second active. The composition may also further comprise a functional excipient.Type: GrantFiled: December 27, 2011Date of Patent: August 28, 2012Inventors: David Wong, Kate Wensie Wong, Spencer Wenyen Wong
-
Patent number: 8241665Abstract: A matrix formulation for a soft chewable capsule is provided which includes a gel-forming composition, a plasticizer, a polymer modifier, and water. The polymer modifier may be a carboxylic acid or other organic compound that alters the physical and/or chemical properties of the capsule formulation. A chewable soft capsule is also provided, having enhanced organo-leptic and processing properties. An active material may be delivered to a user using this dosage form. A method of forming the chewable soft capsule is also provided.Type: GrantFiled: October 10, 2011Date of Patent: August 14, 2012Assignee: Banner Pharmacaps, Inc.Inventors: EmadEldin M. Hassan, Warren W. Kindt, Roger E. Gordon
-
Patent number: 8197842Abstract: A novel dietary supplement and methods for the manufacture of the same are disclosed for feeding to equines and other animals. The dietary supplement of the present invention is beneficial to the health of equines and other animals. The dietary supplement of the present invention consists of safe and natural ingredients rather than drugs, and is orally administrable. The ingredients of the dietary supplement make the dietary supplement of the present invention highly beneficial to the health of equines and other animals.Type: GrantFiled: February 9, 2010Date of Patent: June 12, 2012Assignee: Freedom Health, LLCInventors: Peter M. J. Bedding, Franklin L. Pellegrini
-
Publication number: 20120141574Abstract: A palatable, edible soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The edible soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the edible soft chews do not require the use of heat or the addition of water during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture.Type: ApplicationFiled: February 14, 2012Publication date: June 7, 2012Inventors: Neil E. Paulsen, Roland Johnson, Michael Coffee
-
Patent number: 8168214Abstract: Provided are methods of treating pain, including neuropathic pain, in human and veterinary individuals. These methods employ locally administrable pharmaceutical gallium compositions, including pharmaceutical gallium compositions suitable for administration to the skin and mucous membranes. The compositions comprise pharmaceutically acceptable gallium compounds, such as gallium maltolate or gallium nitrate, together with pharmaceutically acceptable carriers suitable for local administration, including those suitable for topical administration. The administration of such compositions provides relief from pain, itching, allodynia, hyperalgesia, and related symptoms.Type: GrantFiled: November 7, 2007Date of Patent: May 1, 2012Inventor: Lawrence R. Bernstein
-
Patent number: 8147871Abstract: The present invention is directed to novel pharmaceutically acceptable polymeric compositions suitable for melt extrusion and injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form.Type: GrantFiled: March 11, 2005Date of Patent: April 3, 2012Assignee: Capsugel Belgium BVBAInventors: Adrian Brown, Wayne M. Matthews, Daniel M. Margetson, Stephen Mark McAllister, Ronald K. Raby
-
Patent number: 8071123Abstract: Two resin films each provided with an orally administrable edible agent layer are joined so that administrable agent layers face each other, drawn into a nip between a pair of press rolls, pressurized at back surfaces to bond the administrable agent layers together, and conveyed in a direction substantially conforming to a tangential direction at a pressurization zone of the press rolls. A delamination roll disposed in the conveying direction is used to draw only one of the two resin films sandwiching the bonded plural administrable agent layers in a direction different from the conveying direction, while continuously conveying the other resin film retaining the plural administrable agent layers in the conveying direction. This allows only one of the joined two resin films to be delaminated. The obtained pressure bonded product, that is, an orally administrable edible agent of laminate film form can be punched out into predetermined shapes.Type: GrantFiled: December 1, 2003Date of Patent: December 6, 2011Assignee: Kyukyu Pharmaceutical Co., Ltd.Inventors: Yasuo Hayashi, Kazuya Yano, Tsutomu Awamura, Kazuyoshi Sudeji
-
Patent number: 8029818Abstract: The present invention relates to a method for reducing the postprandial glycemic excursion to carbohydrates by feeding supplemental fructose prior to the carbohydrate challenge. The unit does of fructose required to blunt the postprandial glycemic excursion is from about 2 grams to about 30 grams fructose. The fructose source is consumed from about 10 to about 90 minutes before a meal.Type: GrantFiled: May 29, 2002Date of Patent: October 4, 2011Assignee: Abbott LaboratoriesInventor: Bryan W. Wolf
-
Patent number: 8025897Abstract: Fumaric acid is added in amounts sufficient to reduce the burn sensation commonly associated with propionic acid derivatives.Type: GrantFiled: June 12, 2006Date of Patent: September 27, 2011Assignee: McNeil-PPC, Inc.Inventors: Frank J. Bunick, Feng Lin
-
Patent number: 7993669Abstract: A novel dietary supplement and nutritional aid and methods for the manufacture and administration of the same are disclosed for the efficacious treatment and/or prevention of digestive tract ulcers in horses and other animals. The dietary supplement of the present invention is effective in treating and/or preventing gastric ulcers, and in treating colonic ulcers as well. The dietary supplement of the present invention consists of safe and natural ingredients rather than drugs, and is orally administrable. The ingredients of the dietary supplement of the present invention when combined provide a synergistic efficacy which greatly exceeds the sum of the efficacies of the individual ingredients, making the dietary supplement highly effective in the treatment of digestive tract ulcers.Type: GrantFiled: September 13, 2005Date of Patent: August 9, 2011Assignee: Freedom Health, LLCInventors: Peter M. J. Bedding, Franklin L. Pellegrini
-
Patent number: 7988989Abstract: A novel nutritional product and methods for the manufacture and administration of the same are disclosed for the feeding of equine foals and other animals. The nutritional product of the present invention is effective in supporting the growth and health of equine foals, and in supporting and stimulating its immune system as well. The nutritional product of the present invention consists of safe and natural ingredients rather than drugs, and is orally administrable. The ingredients of the nutritional product of the present invention when combined provide a synergistic efficacy which greatly exceeds the sum of the efficacies of the individual ingredients, making the nutritional product highly effective in promoting and enhancing the growth, nutritional uptake, and immune system of equine foals.Type: GrantFiled: March 17, 2004Date of Patent: August 2, 2011Assignee: Freedom Health, LLCInventors: Peter M. J. Bedding, Franklin L. Pellegrini
-
Patent number: 7964189Abstract: The present invention relates to nutritional supplements to be administered to, or to be taken by, women desiring to become pregnant, and pregnant and nursing women. The nutritional supplements of this invention have a unique blend of vitamins, minerals, lycopene, co-enzyme Q10, DHA, docusate (such as docusate sodium), folic acid, and a nutritionally acceptable carrier therefor. The invention includes specific nutritional supplements for the uses set forth above.Type: GrantFiled: September 19, 2008Date of Patent: June 21, 2011Assignee: Argent Development Group, LLCInventors: John C. Morrison, Kenneth R. Greathouse
-
Patent number: 7935362Abstract: Methods and products for delivering a medicament or agent to an individual are provided as well as methods for producing the product. The product includes one or more coatings having a medicament or agent. The coatings can further comprise one or more fat-based confectioneries to provide a coated product that has an improved aesthetic and taste appeal to a consumer. The medicament or agent is present within a coating that surrounds a consumable center. By chewing the coated product, the medicament or agent is released from the product within the buccal cavity.Type: GrantFiled: November 9, 2005Date of Patent: May 3, 2011Assignee: Wm. Wrigley Jr. CompanyInventors: Ronald L. Ream, Leonard Matulewicz, William J. Wokas, Brian Ream
-
Patent number: 7914811Abstract: The present invention provides an oral dosage form for delivering active agents having a soft core with an active agent particles, which have an average size of greater than about 50 ?m, and a brittle shell encasing the soft core, wherein the weight ratio of drug particles to shell being from about 1.0:0.5 to about 1.0:15.Type: GrantFiled: June 29, 2001Date of Patent: March 29, 2011Assignee: McNeil-PPC, Inc.Inventors: Frank J. Bunick, John J. Burke, Timothy P. Gilmor, Michelle Papalini
-
Patent number: 7887832Abstract: Disclosed are popping pharmaceutical compositions, which comprise OTC or prescription drug, and popping material. The popping material includes pressurized gas trapped within cavities of a pharmaceutically acceptable material in a manner that allows the gas to escape from the pharmaceutical composition upon dissolution, contact with saliva or shattering of the popping material. Such an oral pharmaceutical composition may be popular with children that will prefer it on other ones, which do not pop. Methods for preparation of such oral pharmaceutical compositions are also disclosed.Type: GrantFiled: November 23, 2004Date of Patent: February 15, 2011Assignee: CTS Chemical Industries, Ltd.Inventors: Sigal First, Rina Yamin
-
Patent number: 7867509Abstract: Physiologically acceptable films, including edible films, are disclosed. The films include a water soluble film-forming polymer such as pullulan. Edible films are disclosed that include pullulan and antimicrobially effective amounts of the essential oils thymol, methyl salicylate, eucalyptol and menthol. The edible films are effective at killing the plaque-producing germs that cause dental plaque, gingivitis and bad breath. The film can also contain pharmaceutically active agents. Methods for producing the films are also disclosed.Type: GrantFiled: June 3, 2008Date of Patent: January 11, 2011Inventors: Sau-Hung Spence Leung, Robert S. Leone, Lori D. Kumar, Neema Kulkarni, Albert F. Sorg
-
Patent number: 7850988Abstract: Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizes upon compression than previously available.Type: GrantFiled: October 25, 2006Date of Patent: December 14, 2010Assignee: Delavau LLCInventors: Kevin W. Lang, James W. Dibble, Raya Levin, Gregory B. Murphy
-
Publication number: 20100278901Abstract: The present invention includes compositions and methods for reduce the taste of the drug in the drug resin complex. The composition may include one or more drug-resin complexes and a highly compressible, free-flowing pharmaceutical excipient. The resin is present in an amount effective to reduce the taste of the drug in the drug resin complex relative to an otherwise identical pharmaceutical composition without the resin; and wherein the highly compressible, free-flowing pharmaceutical excipient causes release of the drug-resin complex in the mouth.Type: ApplicationFiled: March 4, 2010Publication date: November 4, 2010Applicant: NEOS THERAPEUTICS, LPInventors: Mark TENGLER, Russell Lee McMahen
-
Patent number: 7824706Abstract: A novel dietary supplement and nutritional aid and methods for the manufacture and administration of the same are disclosed for the efficacious treatment and/or prevention of digestive tract ulcers in horses and other animals. The dietary supplement of the present invention is effective in treating and/or preventing gastric ulcers, and in treating colonic ulcers as well. The dietary supplement of the present invention consists of safe and natural ingredients rather than drugs, and is orally administrable. The ingredients of the dietary supplement of the present invention when combined provide a synergistic efficacy which greatly exceeds the sum of the efficacies of the individual ingredients, making the dietary supplement highly effective in the treatment of digestive tract ulcers.Type: GrantFiled: May 9, 2003Date of Patent: November 2, 2010Assignee: Freedom Health, LLCInventors: Peter M. J. Bedding, Franklin L. Pellegrini
-
Publication number: 20100272781Abstract: This invention relates to chewable tablets containing medicants such as gastrointestinal drugs. More particularly, the invention relates to chewable tablets of medicaments that are sugar free and have reduced calories. Accordingly, the tablets of the invention are suitable for both diabetic and non-diabetic patients.Type: ApplicationFiled: March 29, 2010Publication date: October 28, 2010Inventors: Veerappan Subramanian, Muthusamy Shanmugan, Yuh-Herng Eric Lin, Kanni Paranjothy, Kranthikumar Gorlamari
-
Patent number: 7754234Abstract: A composition comprising an antacid, and a local, topical anesthetic. The composition is used to relieve pain or discomfort associated with a sore throat, and therefore, the invention is also directed to a method of alleviating the pain or discomfort associated with a sore throat comprising instructing a human to orally administer the composition.Type: GrantFiled: July 12, 2006Date of Patent: July 13, 2010Inventor: Thomas L. Jones
-
Patent number: 7749513Abstract: The present invention relates to cholesterol-lowering preparations, in particular to a bacterial preparation for use as a medicament for lowering of the blood cholesterol level. The present invention provides inter alia a preparation of Rhodospirillum spp. and/or Phaeospirillum with cholesterol-lowering effects, food supplements and foodstuffs comprising said preparation and methods for the preparation and use thereof.Type: GrantFiled: February 10, 2009Date of Patent: July 6, 2010Assignee: Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek TNOInventors: Josephus Jan Emeis, Christophe Lasseur
-
Patent number: 7727552Abstract: A composition of an oral medicine or an oral medicine which can prevent an unpleasant taste of the medicine is herein disclosed. It is granules, powders, syrups and the like which is prevented from an unpleasant taste, comprising a basic medicine having an unpleasant taste and an anionic polymer such as carrageenan.Type: GrantFiled: March 26, 1998Date of Patent: June 1, 2010Assignee: Eisai R&D Management Co., Ltd.Inventors: Koji Ukai, Tsutomu Hrada, Yasuyuki Suzuki
-
Patent number: 7615235Abstract: The invention relates to thin film-shaped or wafer-shaped pharmaceutical preparations for oral administration of active substances. The preparations contain at least one matrix-forming polymer which has at least one active substance and at least one carbon dioxide-forming substance dissolved or dispersed therein.Type: GrantFiled: February 4, 2003Date of Patent: November 10, 2009Assignee: LTS Lohmann Therapie-Systeme AGInventors: Tina Rademacher, Frank Seibertz, Petra Brandt, Christian Von Falkenhausen, Markus Krumme
-
Publication number: 20090269393Abstract: Disclosed herein is a tablet formulation of an objectionable tasting drug cetirizine or its pharmaceutically acceptable salt in a form of chewable bilayer tablet, wherein the formulation comprises said cetirizine, a combination of water-insoluble and water-soluble polymer in a ratio of about 1:0.5 to about 1:5 and a low molecular weight polyol, wherein the molar ratio of the low molecular weight polyol to cetirizine is more than 10, and the inactive formulation layer comprises beta-cyclodextrin and other pharmaceutically acceptable excipients. Further, the present invention provides a process for preparing the formulation.Type: ApplicationFiled: June 12, 2007Publication date: October 29, 2009Applicant: JUBLIANT ORGANOSYS LIMITEDInventors: Namdev Kashid, Pradeep Chouhan, Gour Mukherji
-
Publication number: 20090246257Abstract: An orally administrable wafer is provided comprising at least one physiologically acceptable film forming agent. The wafer is formed by mixing the film-forming agent with an aqueous solution to form a gel and exposing the gel to a plurality of heating and cooling cycles. The wafer is rapidly dissolving and suitable for administration of pharmaceutical agents.Type: ApplicationFiled: March 27, 2008Publication date: October 1, 2009Inventor: Pankaj Modi
-
Patent number: RE43582Abstract: The subject invention is a carrier or product formed of a matrix having starch, sugar, fat, polyhydric alcohol and water in suitable ratios such that there exists a water activity of 0.6-0.75. The water activity of the product matrix may be adjusted up or down so that the availability of water in the finished product is not detrimental to the included active ingredient, be it pharmaceutical, nutraceutical, or a vitamin mineral complex.Type: GrantFiled: April 29, 2009Date of Patent: August 14, 2012Assignee: EZ-Med Holdings, Inc.Inventor: Edwin H. Christensen